Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

Related Articles by Review for PubMed (Select 18519659)

1.

Profiling of immune response to guide cancer diagnosis, prognosis, and prediction of therapy.

Ambs S, Marincola FM, Thurin M.

Cancer Res. 2008 Jun 1;68(11):4031-3. doi: 10.1158/0008-5472.CAN-08-0521. No abstract available.

2.

[PCR-technology in the diagnosis, prognosis and therapy of oncologic disease].

Vinogradskaia GR, Marinets OV.

Vopr Onkol. 2001;47(1):7-17. Review. Russian. No abstract available.

PMID:
11317541
3.

New molecular assays for cancer diagnosis and targeted therapy.

Lea P, Ling M.

Curr Opin Mol Ther. 2008 Jun;10(3):251-9. Review.

PMID:
18535932
4.

Use of DNA methylation for cancer detection: promises and challenges.

Zhu J, Yao X.

Int J Biochem Cell Biol. 2009 Jan;41(1):147-54. doi: 10.1016/j.biocel.2008.09.003. Epub 2008 Sep 13. Review.

PMID:
18834953
5.

Studying genetic variations in cancer prognosis (and risk): a primer for clinicians.

Savas S, Liu G.

Oncologist. 2009 Jul;14(7):657-66. doi: 10.1634/theoncologist.2009-0042. Epub 2009 Jul 6. Review.

6.

The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activation.

Wolchok JD, Saenger Y.

Oncologist. 2008;13 Suppl 4:2-9. doi: 10.1634/theoncologist.13-S4-2. Review.

7.

Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer.

Ramanathan S, Gagnon J, Ilangumaran S.

Arch Immunol Ther Exp (Warsz). 2008 Sep-Oct;56(5):311-23. doi: 10.1007/s00005-008-0033-2. Review.

PMID:
18836862
8.

From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer.

Angell H, Galon J.

Curr Opin Immunol. 2013 Apr;25(2):261-7. doi: 10.1016/j.coi.2013.03.004. Epub 2013 Apr 8. Review.

PMID:
23579076
9.

MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.

Shi M, Guo N.

Cancer Treat Rev. 2009 Jun;35(4):328-34. doi: 10.1016/j.ctrv.2008.12.002. Epub 2009 Jan 25. Review.

PMID:
19171434
10.

Postinjury immune monitoring: can multiple organ failure be predicted?

Visser T, Pillay J, Koenderman L, Leenen LP.

Curr Opin Crit Care. 2008 Dec;14(6):666-72. doi: 10.1097/MCC.0b013e3283196522. Review.

PMID:
19005307
11.

Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis.

Herceg Z, Hainaut P.

Mol Oncol. 2007 Jun;1(1):26-41. doi: 10.1016/j.molonc.2007.01.004. Epub 2007 Mar 14. Review.

12.

[Genome-wide expression profiling as a clinical tool: are we there yet?].

Geyer FC, Decker T, Reis-Filho JS.

Pathologe. 2009 Mar;30(2):141-6. doi: 10.1007/s00292-008-1104-1. Review. German.

PMID:
19219435
13.

Preclinical development of T cell receptor gene therapy.

Bendle GM, Haanen JB, Schumacher TN.

Curr Opin Immunol. 2009 Apr;21(2):209-14. doi: 10.1016/j.coi.2009.02.007. Epub 2009 Mar 25. Review.

PMID:
19321326
14.

Molecular profiling in the age of cancer genomics.

Lin J, Li M.

Expert Rev Mol Diagn. 2008 May;8(3):263-76. doi: 10.1586/14737159.8.3.263. Review.

PMID:
18598106
15.

Antigen choice in adoptive T-cell therapy of cancer.

Offringa R.

Curr Opin Immunol. 2009 Apr;21(2):190-9. doi: 10.1016/j.coi.2009.02.006. Epub 2009 Mar 16. Review.

PMID:
19297140
16.

Molecular profiling of tumours by immunohistochemistry.

Sarkar C, Das P, Ghosh R.

Natl Med J India. 2007 Nov-Dec;20(6):277-81. Review. No abstract available.

PMID:
18335792
17.

Cancer 1974: an analytical vademecum of oncologic relevance.

DeCarvalho S.

Oncology. 1973;28(4):289-98. Review. No abstract available.

PMID:
4587159
18.

Cytokines and sickness behavior: implications for cancer care and control.

Miller AH.

Brain Behav Immun. 2003 Feb;17 Suppl 1:S132-4. Review. No abstract available.

PMID:
12615199
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk